Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,610
Closed -$80.5K 3352
2025
Q1
$80.5K Hold
36,610
﹤0.01% 3088
2024
Q4
$293K Hold
36,610
﹤0.01% 2887
2024
Q3
$299K Sell
36,610
-10
-0% -$84 ﹤0.01% 2920
2024
Q2
$341K Buy
36,620
+5,890
+19% +$62.7K ﹤0.01% 2862
2024
Q1
$380K Hold
30,730
﹤0.01% 2711
2023
Q4
$335K Buy
30,730
+10
+0% +$89 ﹤0.01% 2792
2023
Q3
$246K Hold
30,720
﹤0.01% 2890
2023
Q2
$295K Buy
30,720
+2,920
+11% +$30.3K ﹤0.01% 2867
2023
Q1
$334K Sell
27,800
-3,206
-10% -$41.9K ﹤0.01% 2735
2022
Q4
$431K Buy
31,006
+2,138
+7% +$25.8K ﹤0.01% 2706
2022
Q3
$262K Buy
28,868
+30
+0.1% +$262 ﹤0.01% 2922
2022
Q2
$230K Buy
28,838
+5,675
+25% +$40.2K ﹤0.01% 2973
2022
Q1
$144K Sell
23,163
-36,416
-61% -$256K ﹤0.01% 3063
2021
Q4
$540K Buy
59,579
+36,726
+161% +$407K ﹤0.01% 2709
2021
Q3
$237K Sell
22,853
-3,498
-13% -$45K ﹤0.01% 3042
2021
Q2
$372K Buy
26,351
+1,980
+8% +$27.4K ﹤0.01% 2935
2021
Q1
$338K Sell
24,371
-7,524
-24% -$115K ﹤0.01% 2848
2020
Q4
$390K Buy
31,895
+14,520
+84% +$189K ﹤0.01% 2709
2020
Q3
$276K Sell
17,375
-18,040
-51% -$305K ﹤0.01% 2846
2020
Q2
$801K Buy
35,415
+4,395
+14% +$73.6K ﹤0.01% 2316
2020
Q1
$312K Buy
+31,020
New +$302K ﹤0.01% 2603

Other funds holding ZYXI

AllianceBernstein's ZYXI Position: Q2 2025 in Review

AllianceBernstein sold out of Zynex (ZYXI) in Q2 2025, closing a stake of 36,610 shares — an estimated $80.5K sold.

AllianceBernstein first reported a position in ZYXI in Q1 2020 and held it in 21 quarters. The position peaked at $801K in Q2 2020. 76 funds tracked by Wall St. Rank hold ZYXI as of Q2 2025.

  • AllianceBernstein reported no remaining Zynex position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 36,610 Zynex shares in Q2 2025, an estimated $80.5K.
  • AllianceBernstein first reported a position in Zynex in Q1 2020 and held it in 21 quarters.
  • AllianceBernstein's Zynex position peaked at $801K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Zynex as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.